Creator Post Archive
Investing Portfolio Pathway
Browse the full post archive, then jump into the source post to inspect linked mentions and linked signals.
May 13, 2026
Meta $META Q1 2026 Earnings Review 8 May 2026
Meta's Q1 2026 earnings show strong revenue growth driven by advertising performance, despite concerns about high capex for AI infrastructure. The company is seeing increased engagement and conversion rates due to advanced AI models and improved ad targeting, with free cash flow funding significant investments in future technology.
May 13, 2026
CorMedix $CRMD Q1 2026 Earnings Preview
CorMedix ($CRMD) is set to report Q1 2026 earnings on May 14th. The company previously beat revenue estimates but missed earnings estimates. Analysts have lowered estimates for the upcoming quarter, and the stock shows negative relative strength with high short interest.
May 12, 2026
Alphabet $GOOG Q1 2026 Earnings Review 8 May 2026
Alphabet's Q1 2026 earnings show significant revenue growth, particularly in Google Cloud, which is becoming a key growth engine. While net income nearly doubled, a large portion was an equity investment windfall. The company made substantial investments in acquisitions and infrastructure, issuing new debt despite holding significant liquidity. Potential antitrust issues and pending appeals pose friction points.
May 12, 2026
Amazon $AMZN Q1 2026 Earnings Review 8 May 2026
The creator reviews Amazon's Q1 2026 earnings, highlighting strong revenue growth driven by AWS and AI investments. Despite a significant drop in free cash flow due to heavy capital expenditures on AI infrastructure, the creator views this as a strategic move for future growth and maintains a bullish stance on the stock, intending to buy more on pullbacks.
May 9, 2026
United Health $UNH Stock Review 8 May 2026
United Health ($UNH) reported strong Q1 2026 earnings with revenue growth and an EPS beat. The company is focusing on AI investments for modernization, administrative simplification, and clinical workflows, alongside a strategy to reduce prior authorizations. They are also exiting non-US businesses and reallocating capital to healthcare initiatives.
May 7, 2026
Rocket Lab $RKLB Q1 2026 Earnings Preview
Rocket Lab USA is set to report Q1 2026 earnings, with analysts expecting revenue of $189.41 million and EPS of -$0.04. The stock shows an uptrend with positive relative strength, despite a history of missing forward estimates. Short interest stands at 8.45%.
May 7, 2026
Genmab $GMAB Q1 2026 Earnings Preview
Genmab is set to report Q1 earnings on May 7th. The company missed revenue and earnings estimates last quarter. Analysts have lowered estimates for this quarter, and the options market is pricing in a 3.6% move. Genmab has a history of beating forward estimates and shows positive relative strength.
May 6, 2026
F&G Annuities & Life $FG Q1 2026 Earnings Preview
F&G Annuities & Life ($FG) is set to report Q1 earnings on May 6th. The company beat revenue estimates last quarter but missed on EPS. Analysts have lowered estimates recently, and FG's historical estimate beat rate is 33%. The stock is consolidating with positive relative strength, and the options market implies an 11.6% move.
May 6, 2026
Fidelity National Financial $FNF Q1 2026 Earnings Preview
This is an earnings preview for Fidelity National Financial ($FNF) for Q1 2026. The company's previous quarter saw revenue beat but earnings miss estimates. Current estimates project $3.61 billion in revenue and $1.9 cents per share for this quarter. FNF has shown positive relative strength and consolidation price action.
May 6, 2026
Lyft $LYFT Q1 2026 Earnings Preview
Lyft is set to report Q1 earnings on May 7th. The company missed revenue estimates in the previous quarter but beat earnings estimates. Analysts have mixed outlooks for the upcoming report, with a significant portion lowering estimates. The stock is in a consolidation trend with positive relative strength, but faces high short interest.
May 6, 2026
Realty Income $O Q1 2026 Earnings Preview
Realty Income is set to report Q1 earnings with revenue estimates at $1.39 billion and FFO at $1.10 per share. The stock shows positive relative strength and consolidation, with a 3.3% short interest. The options market is pricing in a 3.6% move.
May 5, 2026
Warner Brothers Discovery $WBD Q1 2026 Earnings Preview
Warner Brothers Discovery ($WBD) is set to report Q1 earnings with expectations of $8.89 billion in revenue and a loss of 10 cents per share. The stock is currently in consolidation with negative relative strength, and the options market is pricing a small implied move.
May 5, 2026
Uber $UBER Q1 2026 Earnings Preview
Uber is set to report Q1 2026 earnings on May 6th. While the company beat revenue estimates in the previous quarter, it missed on earnings per share. Analysts have mixed outlooks for the upcoming report, with mixed estimate revisions and a 67% historical beat rate for forward estimates. The stock is currently consolidating with positive relative strength, and the options market is pricing in a 7.2% move.
May 4, 2026
Novo Nordisk $NVO Q1 2026 Earnings Preview
Novo Nordisk ($NVO) is set to report Q1 earnings on May 6th. The company has a strong track record of beating estimates and is currently showing positive relative strength. The options market is anticipating a move of approximately 7.3%.
May 4, 2026
Jackson Financial $JXN Q1 2026 Earnings Preview
Jackson Financial ($JXN) is set to report Q1 earnings on May 5th. The company beat estimates last quarter and is expected to report $1.94 billion in revenue and $5.96 EPS this quarter. The stock is in an uptrend with positive relative strength, though the options market is pricing an 8.9% move.
May 4, 2026
Prudential $PRU Q1 2026 Earnings Preview
Prudential Financial (PRU) is set to report Q1 earnings on May 5th. While PRU has a strong history of beating revenue estimates, recent analyst estimate revisions have been downward. The stock is currently consolidating with positive relative strength, and the options market is pricing a 5.1% move.
May 4, 2026
Pfizer $PFE Q1 2026 Earnings Preview
Pfizer (PFE) is set to report Q1 earnings on May 5th. While the company has a history of beating estimates, recent analyst revisions and negative relative strength suggest caution heading into the report. The options market is pricing a modest move.
May 4, 2026
Palantir $PLTR Q1 2026 Earnings Preview
This is a preview of Palantir Technologies' Q1 2026 earnings report. The company beat revenue and EPS estimates in the previous quarter. Analysts have been raising estimates, and Palantir historically meets or beats forward estimates. The options market is pricing in a move of approximately 9.8%, and short interest stands at 2.32%.
May 3, 2026
ADMA Biologics $ADMA Stock Review
The creator reviews ADMA Biologics ($ADMA), a biofarmaceutical company, noting its current underperformance and bearish technical indicators despite positive analyst ratings and strong EPS growth projections. The stock is trading below its fair value, with mixed signals on momentum and accumulation.
May 3, 2026
Apple $AAPL FY Q2 2026 Results and Analysis
Apple reported strong Q2 FY26 results with record revenue and EPS, driven by iPhone and Services growth, and significant AI integration. Despite supply constraints, the company announced a $100 billion share repurchase program and a 4% dividend increase. A leadership transition is planned for September 1st, with Tim Cook moving to executive chairman.
May 1, 2026
Chevron $CVX Q1 2026 Earnings Preview
Chevron is set to report Q1 earnings on May 1st. While the company has a history of beating revenue estimates, analysts have recently lowered earnings expectations. The stock is in consolidation with positive relative strength, and the options market is pricing a modest move.
Apr 30, 2026
HESS Midstream $HESM Q1 2026 Earnings Preview
Hess Midstream ($HESM) is set to report Q1 earnings with revenue estimates lower than the previous quarter. Analysts have lowered estimates recently, and the stock has a short interest of 6.1%. The options market is pricing in a potential move of around 4.8%.
Apr 30, 2026
NNN REIT $NNN Q1 2026 Earnings Preview
NNN REIT is set to report Q1 earnings with analysts expecting revenue of $238.39 million and FFO of $0.86 per share. The stock is currently in consolidation with negative relative strength and a 3.55% short interest. The options market is pricing in a 5% move.
Apr 30, 2026
Hershey $HSY Q1 2026 Earnings Preview
Hershey (HSY) is set to report Q1 2026 earnings with analysts expecting $3.03 billion in revenue and $2.04 EPS. While the company historically beats estimates, recent price action shows distribution and negative relative strength, with a notable 5.85% short interest.
Apr 30, 2026
Altria $MO Q1 2026 Earnings Preview
Altria is set to report Q1 2026 earnings, with analysts expecting $4.58 billion in revenue and $1.25 per share. The stock is in an uptrend with positive relative strength, and has historically met or beaten estimates. The options market is pricing in a 3.8% move.
Showing 26-50 of 81 posts · Page 2 of 4